Company intelligence / Profile preview

URAL Telekom

Antalya, Antalya, Turkeyuraltelekom.com ↗

Ownership: Private
Development stage: Other

Overview

URAL Telekom develops and commercializes AI-powered software solutions for medical image analysis in ophthalmology and cardiology. Their flagship product EyeCheckup is used for early detection of over 20 eye diseases and has received recognition including an EU Horizon grant[8]. The company’s NEW VISION suite includes FDA-approved software for ophthalmic image processing.

Therapeutic areas: CardiovascularOphthalmology
Modalities: Software as a Medical DeviceArtificial Intelligence
Industry: Medical Imaging

Partnerships

European Union Horizon program Ventures Thrive grant[2][8]

Beyond the preview

Go deeper on URAL Telekom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on URAL Telekom.

Explore the full profile